Stock Snapshot from
Biota Pharmaceuticals IncAdd to My Watchlist
BOTA:USNASDAQ GSIndustry: Medical-Biomedical/Gene
- 3.46Last
- 0.01 -0.29%Today's Change
- 3.47Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -- |
| EPS: Year Est. 12/12 ttm | -- |
| EPS: Quarterly Actual | -- |
| EPS: Quarterly Est. | -- |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | -- |
Company Description
| Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections. | |
| Revenue | $15 million |
| Net Income | $-5 million |
| Total Assets | $98 million |
| Employees | 16 |
| Web Site | www.biotapharma.com |
Latest Headlines
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.